Overview
Takamasa Suzuki-Maruyama practices in Kasugai, Japan. Suzuki-Maruyama is rated as an Experienced expert by MediFind in the treatment of Neurogenic Bladder. Their top areas of expertise are Retinoblastoma, MELAS Syndrome, Gliomatosis Cerebri, and Glioma.
Their clinical research consists of co-authoring 185 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 1 article in the study of Neurogenic Bladder.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- AstrocytomaSuzuki-Maruyama isExperienced. Learn about Astrocytoma.
- GlioblastomaSuzuki-Maruyama isExperienced. Learn about Glioblastoma.
- GliomaSuzuki-Maruyama isExperienced. Learn about Glioma.
- Gliomatosis CerebriSuzuki-Maruyama isExperienced. Learn about Gliomatosis Cerebri.
- MELAS SyndromeSuzuki-Maruyama isExperienced. Learn about MELAS Syndrome.
- Neurogenic BladderSuzuki-Maruyama isExperienced. Learn about Neurogenic Bladder.